Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Activities of daily living: evaluation and treatment in persons with multiple sclerosis.
Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis.
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Building a better sphingosine kinase-1 inhibitor.
Disease-modifying therapies in Chinese children with multiple sclerosis.
Twin studies and the heritability of MS: a conclusion.
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Myelination of the nervous system: mechanisms and functions.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Optic nerve disease and axon pathophysiology.
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Structure and Activity of the Acid Sensing Ion Channels.
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab For Relapsing-Remitting Multiple Sclerosis.

Pages